The Veteran's prostate cancer residuals are rated as 60 percent disabling, effective April 1, 2016. The reduction from 100 percent to 60 percent was proper and restoration is denied. The Veteran’s erectile dysfunction is not service-connected and a compensable rating is denied. From April 1, 2016 to December 11, 2019, the Veteran's service-connected disabilities rendered him unable to secure and follow a substantially gainful occupation, qualifying for TDIU benefits. From February 19, 2016 to March 31, 2016, he was rated as totally disabled due to prostate cancer alone, meeting criteria for SMC at the housebound rate.
The deciding factor: The reduction from a 100% rating to a 60% rating for prostate cancer residuals was proper based on evidence showing no local recurrence or metastasis of the Veteran's prostate cancer after treatment cessation. The Veteran’s service-connected erectile dysfunction is not manifested by deformity of the penis, and his prostate cancer alone rendered him unable to secure and follow a substantially gainful occupation from April 1, 2016 to December 11, 2019.
- Claimed conditions
- Prostate cancer
- How they argued it
- Direct service connection
- Exposure basis
- None
- Rating
- Not verified here — check the original decision
- Decision date
- March 18, 2020
- Citation
- 20020209
This is a plain-language summary generated by AI from a public Board of Veterans’ Appeals decision. It can contain errors — always verify against the original. Read the original VA decision (opens in a new tab) using citation 20020209.
What this means for you
A final Board denial may be appealed to the U.S. Court of Appeals for Veterans Claims, generally within 120 days of the Board mailing date. A Supplemental Claim with new and relevant evidence is a separate option. Another Higher-Level Review of the Board decision is not available. Check your own notice: this historical decision does not set your deadline.
What you can do next
Use your own notice and decision stage. A remanded issue is not a final court-appealable denial. VA review guidance and CAVC filing instructions (U.S. federal; reviewed October 7, 2026).
Related decisions
Other Board decisions on a similar condition or argued the same way.
- Whole decision: Granted
The Veteran's arteriosclerotic heart disease is rated at 100% effective October 25, 2024. His prostate cancer residuals are rated at 60% effective October 25, 2024.
- Whole decision: Granted
The Veteran's acquired psychiatric disorder and prostate cancer are granted service connection, with the latter requiring a VA examination to address exposure to burn pits.
- Whole decision: Denied
The Veteran's claim for service connection for hearing loss in the right ear has been denied. The Board found that there is no current diagnosis of right ear hearing loss and thus, cannot establish a link to service. For prostate cancer, the Veteran's claim is remanded as VA did not provide an opinion regarding whether his condition may be related to service due to toxic exposure.
- Whole decision: Denied
The Veteran's prostate cancer residuals prior to January 5, 2026 are rated at 10 percent. From January 5, 2026, the Veteran is granted a 20 percent rating for his prostate cancer residuals. The Veteran's left ear hearing loss is not compensable.
Free starter guide for your own claim
Reading this because you were denied or under-rated? Get the plain-English next steps — your appeal options, the deadline that protects you, and how appeals like yours turn out. One email, no spam.
We will only use this to send the guide. No spam, unsubscribe any time. We never sell your information.
We are not the VA. Veterans’ Rights is an independent resource built for veterans. We are not the U.S. Department of Veterans Affairs, not part of the government, and not endorsed by any government agency.
This is general information, not legal advice. For advice about your own situation, talk to a VA-accredited representative — many help for free.